Free Trial

Comerica Bank Increases Stake in Axon Enterprise, Inc $AXON

Axon Enterprise logo with Aerospace background

Key Points

  • Comerica Bank increased its holdings in Axon Enterprise, Inc by 8.2% in the first quarter, acquiring an additional 6,897 shares, bringing its total to 91,215 shares valued at approximately $47.97 million.
  • Insider sales included notable transactions by Director Michael Garnreiter and CRO Cameron Brooks, with Garnreiter selling 5,913 shares valued at $4.49 million and Brooks selling 3,000 shares for $2.22 million.
  • Analysts have given Axon Enterprise a Moderate Buy rating with price targets ranging from $800 to $900, following solid quarterly earnings that surpassed analysts' expectations.
  • Need better tools to track Axon Enterprise? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Comerica Bank increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 8.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 91,215 shares of the biotechnology company's stock after buying an additional 6,897 shares during the quarter. Comerica Bank owned 0.12% of Axon Enterprise worth $47,974,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in AXON. TCTC Holdings LLC lifted its holdings in Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after purchasing an additional 24 shares in the last quarter. Fourth Dimension Wealth LLC purchased a new position in Axon Enterprise during the fourth quarter valued at approximately $30,000. Bartlett & CO. Wealth Management LLC lifted its holdings in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after purchasing an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new position in Axon Enterprise during the first quarter valued at approximately $32,000. Finally, Alpine Bank Wealth Management purchased a new position in Axon Enterprise during the first quarter valued at approximately $40,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Axon Enterprise Price Performance

Shares of AXON stock traded up $0.66 during mid-day trading on Wednesday, hitting $769.68. The company had a trading volume of 327,103 shares, compared to its average volume of 708,595. The stock's 50 day moving average price is $772.52 and its 200-day moving average price is $675.87. Axon Enterprise, Inc has a 52-week low of $346.71 and a 52-week high of $885.91. The company has a market capitalization of $60.42 billion, a P/E ratio of 190.04, a P/E/G ratio of 28.22 and a beta of 1.36. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. During the same quarter in the previous year, the business posted $1.20 earnings per share. Axon Enterprise's quarterly revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling

In related news, President Joshua Isner sold 15,919 shares of the business's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the sale, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Hadi Partovi purchased 1,358 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, August 13th. The stock was acquired at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the transaction, the director directly owned 237,938 shares of the company's stock, valued at $176,074,120. The trade was a 0.57% increase in their position. The disclosure for this purchase can be found here. Insiders have sold a total of 43,790 shares of company stock valued at $33,654,451 in the last three months. Corporate insiders own 4.40% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Bank of America lifted their price target on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Northland Securities set a $800.00 price target on shares of Axon Enterprise in a report on Tuesday, August 5th. Raymond James Financial reaffirmed an "outperform" rating and set a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Craig Hallum raised shares of Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price target on the stock in a report on Tuesday, August 5th. Finally, Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the stock an "overweight" rating in a report on Friday, July 11th. Thirteen equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $837.69.

Check Out Our Latest Stock Analysis on AXON

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines